Preprint
Article

This version is not peer-reviewed.

Maternal Mortality Trends in the Context of the ReMaP Project and the Implementation of the Alyne Network: A Time-Series Analysis

Submitted:

03 November 2026

Posted:

04 November 2026

You are already at the latest version

Abstract
Objective: Analyze maternal mortality trends in the state of São Paulo, comparing the periods before and after the emergence and implementation of the ReMaP Project (Restructuring and Redesign of the Maternal and Perinatal Care Network in the State of São Paulo) and the establishment of the Alyne Network (Rede Alyne), while stratifying the data according to the sociodemographic and clinical characteristics of pregnant and postpartum women of reproductive age (10–49 years). Methods: Retrospective epidemiological, ecological and longitudinal study with time series analysis of maternal deaths in women aged 10 to 49 years in São Paulo, from 2010 to 2025. Data were extracted from the Brazilian Obstetric Observatory panel and divided into two periods: pre-pandemic (2010–2019) and pandemic/post-pandemic (2020–2025). Descriptive and inferential analysis was carried out using Pearson's chi-square test (p< 0.05). Results: 2,795 deaths were analyzed in the first period and 1,499 in the second. There was a reduction in the proportion of deaths among white women (55.7% to 50.8%) and an increase among brown women (33.0% to 36.2%) and black women (8.6% to 11.3%). There was a drop in direct maternal deaths (60.0% to 50.0%) and an increase in indirect deaths (37.2% to 45.6%). The hospital environment concentrated more than 91% of cases. Although medical assistance before death increased (70.9% to 79.3%), the performance of autopsies fell from 36.7% to 18.3%, and investigation by committees decreased from 42.9% to 32.2%. Conclusions: The temporal transition highlighted the increase in indirect causes and the worsening of racial inequalities in maternal mortality in São Paulo. Despite the expansion of pre-death assistance registration, weaknesses were detected in post-pandemic epidemiological surveillance, indicating the need to strengthen investigation committees and improve care networks.
Keywords: 
;  ;  ;  ;  

1. Introduction

Maternal mortality remains an important indicator of inequality and development in global health systems. According to data from the World Health Organization (WHO), a maternal death occurs every approximately 2 minutes worldwide, demonstrating the magnitude and urgency of this public health issue [1]. Between 2000 and 2023, there was a reduction of approximately 40% in the maternal mortality ratio (MMR) globally, indicating that progress is possible when there is adequate investment in health systems [2]. However, this global reduction masks significant disparities between regions and countries, particularly between high-income nations and low- and middle-income nations, where obstetric complications are the main causes of death [1,2].
Racial and ethnic disparities in maternal mortality are an alarming reality that reflects centuries of systemic structures of health inequities [3]. In the United States, the pregnancy-related mortality rate among black women is approximately 2.6 times higher compared to that of white women, with a ratio of 68.0 deaths per 100,000 live births among black individuals versus 26.3 among white individuals in the period 2018 to June 2024 [4]. In the United Kingdom, women from aggregated black and Asian ethnic groups have significantly higher maternal mortality compared to those from white ethnic groups [5].
Social determinants of health (SDOH) play a fundamental role in understanding and preventing maternal mortality [6]. Recent evidence from systematic reviews indicates that factors such as socioeconomic status, race and ethnicity, health insurance, education, and access to prenatal care are significantly associated with the risk of maternal death and severe maternal morbidity [7]. These determinants do not act in isolation; rather, they intersect in complex ways, amplifying vulnerabilities within specific populations. Understanding these structural factors is essential for developing effective interventions that go beyond treating the clinical consequences of obstetric complications to address the systemic root causes that perpetuate preventable maternal deaths. The intersection of race, gender, class, and other markers of social inequality is particularly important for informing policies and practices that promote equity in maternal health [8].
Severe obstetric complications form the clinical basis of maternal mortality and require robust health systems for early identification and appropriate management [9]. Complications such as obstetric hemorrhage, hypertensive disorders, amniotic fluid embolism, infections, and cardiovascular diseases remain leading causes of maternal death, especially in resource-limited settings. Recent data from maternal safety surveillance in Japan show that the proportion of maternal deaths attributed to obstetric hemorrhage has decreased (from 28% in 2010 to 10% in 2023), while suicide has emerged as a significant cause—highlighting the need to integrate mental health approaches into maternal care [10]. Obstetric-specialized intensive care units offer opportunities for advanced monitoring and critical therapeutic interventions, particularly for women with severe obstetric complications, underscoring the role of healthcare infrastructure in reducing maternal mortality [11].
The COVID-19 pandemic revealed critical vulnerabilities in healthcare systems and amplified pre-existing disparities in maternal health [4]. While some studies show an overall reduction in maternal mortality, analysis by race/ethnicity has revealed that the pandemic may have further widened racial disparities in maternal mortality, with potential disproportionate increases among Black women [12]. These findings underscore how public health crises can differentially impact already marginalized populations and how contexts of systemic stress exacerbate pre-existing structural inequalities. Ongoing surveillance and analyses stratified by sociodemographic factors are essential for monitoring trends and identifying populations in need of urgent, targeted interventions.
Reducing maternal mortality requires a multisectoral approach that integrates rigorous epidemiological surveillance, assessments of preventability, the strengthening of healthcare systems, and, fundamentally, structural actions that address the social determinants of health and institutional racism [13]. Maternal mortality review committees—when well-funded and composed of multidisciplinary teams provide critical data on causes, preventable circumstances, and recommendations for prevention. Evidence-based interventions must be adapted to the sociocultural and resource contexts in which they are implemented, with a particular emphasis on ensuring equitable access to prenatal care, quality obstetric care, and comprehensive postpartum care. Public policies aimed at reducing structural inequalities, improving access to education and economic security, and integrating mental healthcare into obstetric care are critical components for eliminating preventable maternal deaths and achieving equity in maternal health [14].
Maternal mortality remains a critical indicator of inequality and the quality of healthcare systems, even in economically developed regions such as São Paulo. Although the state concentrates resources, infrastructure, and expertise in maternal health, maternal mortality rates remain above the targets set by the Sustainable Development Goals (SDGs), demonstrating that economic development does not guarantee equity in reproductive health.
Given this context, the question arises: has the implementation of the "Reestruturação e Redesenho da Rede de Atenção Materna e Perinatal (ReMaP)" (ReMaP) project and the initiatives of the "Alyne Network" (Rede Alyne) altered the trend of maternal mortality in São Paulo? The implementation of coordinated care policies and networks such as ReMaP and the actions structured by the Alyne Network represents an institutional effort to improve the quality of obstetric care and the surveillance of maternal deaths. Determining whether these interventions have effectively shifted maternal mortality trends is essential for: evaluating the effectiveness of public policies in maternal health; identifying whether inequalities persist and within which populations; informing future strategies to prevent avoidable maternal deaths; and contributing to scientific knowledge regarding how structured networks can impact health equity indicators.
Thus, this study aimed to analyze maternal mortality trends in the state of São Paulo, comparing the periods before and after the emergence and implementation of the ReMaP Project (Restructuring and Redesign of the Maternal and Perinatal Care Network in the State of São Paulo) and the establishment of the Alyne Network (Rede Alyne), while stratifying the data according to the sociodemographic and clinical characteristics of pregnant and postpartum women of reproductive age (10–49 years). This analysis was conducted using the ReMaP dashboard, which is linked to the Observatório Obstétrico Brasileiro (OOBr).

2. Materials and Methods

2.1. Type of Study

This is an observational, population-based epidemiological study, with a retrospective ecological design and a comparative approach to historical periods. Maternal deaths occurring in the state of São Paulo, Brazil, between 2010 and 2025 were analyzed, structured into two temporal blocks of analysis: the pre-pandemic period (2010-2019) and the pandemic/post-pandemic period (2020-2025). The study followed the recommendations of the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) [15] checklist for observational studies, adapted to the ecological design used.

2.2. Study Setting

The study was conducted in the state of São Paulo, located in the Southeast region of Brazil. As the country’s most populous federative unit, it exhibits significant demographic, economic, and healthcare-related heterogeneity. The choice of the state of São Paulo is justified by its demographic importance, the high concentration of births, and the availability of structured information systems, which allow for robust analyses of maternal mortality over time.

2.3. Study Period

All maternal deaths recorded between January 1, 2010, and December 31, 2025, were included. For analytical and comparative purposes, the data were grouped into two distinct periods: the pre-pandemic period (2010–2019) and the pandemic and post-pandemic period (2020–2025). This stratification was adopted to enable the assessment of potential changes in the profile of maternal mortality associated with the context of the COVID-19 pandemic and its consequences for maternal healthcare.
The temporal classification also considered the historical and institutional context of maternal healthcare policies in Brazil, particularly the development of the ReMaP project (Restructuring and Redesign of the Maternal and Perinatal Care Network in the State of São Paulo) and the establishment of the Alyne Network (Rede Alyne). The first period (2010–2019) represents the historical baseline, preceding the COVID-19 pandemic and the development of these more recent initiatives. The second period (2020–2025) encompasses the pandemic and post-pandemic context, including the development of ReMaP and the subsequent establishment of the Alyne Network, formally instituted in September 2024 through Ministry of Health Ordinance No. 5,350/2024. Therefore, this period captures not only the effects of the pandemic on maternal healthcare but also the evolving institutional and policy responses aimed at restructuring maternal and perinatal care networks, strengthening healthcare coordination, and improving maternal mortality surveillance. It is important to emphasize that these temporal comparisons were not designed to isolate or establish the causal effects of either initiative, but rather to contextualize changes in maternal mortality within the broader epidemiological and policy landscape in which these initiatives emerged.

2.4. Study Population

The study population consisted of all maternal deaths of women of reproductive age (10–49 years) recorded in the state of São Paulo between 2010 and 2025. Records classified as direct, indirect, or unspecified maternal deaths—identified using the corresponding codes from the Tenth Revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10)—were included. No sampling criteria were applied, as the study utilized the entire set of records available for the period under analysis.

2.5. Data Source and Data Collection

The data used in this study were obtained through the ReMaP Panel, an analytical platform linked to OOBr [16], developed with the objective of monitoring indicators related to maternal and perinatal health in Brazil, supporting processes of surveillance, planning, evaluation and management of health care networks. ReMaP integrates and systematizes information from official databases of the Ministry of Health, especially the Mortality Information System (SIM), allowing structured access to maternal death records and their epidemiological, care and territorial characteristics. The platform provides consolidated and updated data, enabling temporal and comparative analyzes at different geographic and administrative levels.
For this study, all records of maternal deaths that occurred in the state of São Paulo between January 1, 2010 and December 31, 2025 were extracted. The collection was carried out directly in the ReMaP panel through specific queries to the variables of interest, covering sociodemographic, obstetric, care and information related to maternal death surveillance. After extraction, the data was exported to electronic spreadsheets, being subjected to the steps of checking consistency, organization, standardization of analytical categories and consolidation of information. Next, the database was built for statistical analysis and interpretation of results.

2.6. Study Variables

The temporal variable was represented by the year in which the death occurred. The sociodemographic variables analyzed included: race/skin color (White, Black, Brown, Asian, Indigenous, or unknown); educational attainment (no formal education, elementary school [grades 1–5], elementary school [grades 6–9], high school, incomplete higher education, complete higher education, or unknown); and marital status (single, married, in a stable union, separated/divorced, widowed, or unknown). The obstetric variables comprised: the period in which the death occurred (during pregnancy, childbirth, or abortion; puerperium up to 42 days; late puerperium; unrelated to pregnancy/puerperium; or unknown); the type of maternal death (direct, indirect, or unspecified); and the ICD-10 chapter associated with the underlying cause of death. The healthcare and surveillance variables included: the location of the death (hospital, home, another healthcare facility, a public thoroughfare, or other locations); the provision of medical care; whether an autopsy was performed; and whether the death was investigated by a Maternal Mortality Committee.

2.7. Data Analysis and Interpretation

Initially, a descriptive analysis of the data was performed by calculating absolute (n) and relative (%) frequencies, which allowed for the characterization of the profile of maternal deaths across the analyzed periods. To facilitate comparisons between the pre-pandemic period (2010–2019) and the pandemic/post-pandemic period (2020–2025), records were aggregated into temporal blocks, and the proportional distribution of the variables under study was calculated for each period.
In addition to the descriptive analysis, inferential analyses were conducted to assess statistically significant differences between the periods studied. The association between categorical variables and the period in which the death occurred was investigated using Pearson’s chi-square (χ²) test. P-values ​​of less than 0.05 were considered statistically significant.
To assess racial inequalities in maternal mortality, a specific analysis was performed based on race/skin color, using white women as the reference category. Absolute and relative frequencies of deaths by race/skin color were calculated for each period, along with the Risk Ratio (RR) relative to white women. Furthermore, the relative change between the periods was estimated, and the chi-square test was applied to determine whether an association existed between race/skin color and the period in which the death occurred. This analysis made it possible to measure potential shifts in the racial distribution of maternal deaths and to identify patterns of inequality over time. For variables related to the obstetric profile—specifically the type of maternal death and the period in which the death occurred—measures of temporal comparison were calculated, including absolute change (expressed in percentage points) and relative change between the analyzed periods. The observed differences were evaluated using statistical significance tests, making it possible to identify changes in the proportions of direct, indirect, and unspecified maternal deaths, as well as shifts in the timing of these deaths throughout the pregnancy and postpartum period.
Indicators related to data quality and the epidemiological surveillance of maternal mortality were also developed. The study assessed the proportions of deaths involving medical care, autopsies, and investigations by a Maternal Mortality Committee (MMC). For each indicator, absolute and relative frequencies, temporal variations, and the statistical significance of differences between the periods were estimated. The analysis of these indicators aimed to examine potential changes in the quality of care provided to women, as well as the capacity of surveillance systems to investigate and classify maternal deaths. Particular attention was given to investigations by Maternal Mortality Committees and the performance of autopsies, given their fundamental role in accurately determining causes of death and improving prevention strategies.
Data processing, organization, and analysis were conducted using IBM SPSS Statistics® software. Descriptive statistical procedures were employed to calculate absolute and relative frequencies, while inferential analyses—specifically Pearson’s chi-square test—were used to compare distributions across the study periods. Additionally, measures of association and temporal comparison were calculated, including the Risk Ratio (RR), absolute changes (in percentage points), and relative changes (%). A significance level of 5% (p<0.05) was adopted for all analyses.

2.8. Ethical Aspects

The study relied exclusively on secondary data from the public domain, with no access to nominal information or data that would allow for the individual identification of the women included in the analysis. In accordance with Resolution 466/2012 of the National Health Council [17], research that utilizes public, aggregated databases—without participant identification is exempt from review by a Research Ethics Committee.

3. Results

The comparison between the periods 2010–2019 and 2020–2025 revealed important changes in the sociodemographic profile of women who died as mothers. Although white women remained the most frequent group, a reduction in their proportional participation was observed (55.7% to 50.8%), accompanied by an increase in the participation of mixed-race women (33.0% to 36.2%) and black women (8.6% to 11.3%). This pattern suggests the persistence and possible worsening of racial inequalities related to maternal mortality. Regarding education, there was a significant reduction in missing records (44.2% to 10.8%), indicating an improvement in the quality of information. Simultaneously, there was an increase in the participation of women with secondary education (22.1% to 50.6%) and completed higher education (5.7% to 13.2%). Regarding marital status, single women remained predominant in both periods, although with a proportional reduction (50.1% to 44.9%), while the frequency of women in stable unions increased from 8.9% to 11.3% (Table 1).
The distribution of deaths according to the period of occurrence showed that most maternal deaths occurred during the postpartum period, up to 42 days after delivery, in both periods, corresponding to 58.3% of cases in 2010–2019 and 56.6% in 2020–2025. An increase was observed in the proportion of deaths occurring during pregnancy, childbirth, or abortion (26.5% to 29.4%) and a reduction in late deaths, occurring between 43 days and less than one year after delivery (7.9% to 4.5%). Regarding the type of maternal death, a decrease in direct deaths (60.0% to 50.0%) and an increase in indirect deaths (37.2% to 45.6%) were observed, highlighting a greater contribution from pre-existing clinical conditions or those aggravated by pregnancy. Regarding the classification by ICD-10, practically all deaths remained classified in Chapter XV (Pregnancy, childbirth and the puerperium), representing more than 98% of the records in both periods (Table 2).
The results demonstrated that maternal deaths occurred predominantly in hospital settings in both periods analyzed, representing approximately 92% of cases. Occurrences at home and other healthcare facilities remained relatively low and stable over time. Regarding medical care, there was an increase in the proportion of women who received care before death (70.9% to 79.3%) and a reduction in missing records, suggesting improvements in healthcare coverage or in the quality of completion of death certificates. On the other hand, there was a significant reduction in the performance of autopsies, from 36.7% to 18.3%, accompanied by an increase in records without autopsy and those classified as missing. Regarding epidemiological surveillance, there was a decrease in the proportion of deaths investigated by Maternal Mortality Committees (42.9% to 32.2%) and a significant increase in cases without information on investigation (22.9% to 34.6%). This scenario suggests potential weaknesses in the monitoring and investigation processes of maternal deaths in the most recent period, especially considering the impacts of the COVID-19 pandemic on health and surveillance services (Table 3).
Analysis of racial disparities revealed significant changes in the racial composition of maternal deaths between the periods 2010–2019 and 2020–2025. Although white women remained the most frequent group, their relative participation decreased from 55.7% to 50.8%, corresponding to a reduction of 8.7%. In contrast, there was an increase in the participation of mixed-race women, who rose from 33.0% to 36.2% (+9.7%), and, especially, of black women, whose proportion increased from 8.6% to 11.3%, representing a relative growth of 31.3%. The risk ratios in relation to white women also showed an increase in the most recent period, rising from 0.59 to 0.71 among mixed-race women and from 0.15 to 0.22 among black women. The chi-square test demonstrated a statistically significant association between race/color and the period of occurrence of deaths (χ²=14.482; p=0.0007), indicating that the racial distribution of maternal mortality has changed over time. These results suggest the persistence and possible worsening of racial inequalities in maternal mortality, reinforcing the need for public policies aimed at racial equity and addressing the structural inequities that affect access to and quality of healthcare for Black women (Table 4).
Temporal analysis of the type of maternal death revealed changes in the epidemiological profile of deaths between the periods studied. Direct maternal deaths remained predominant, but showed a significant reduction from 60.0% to 50.0% (p<0.001), corresponding to a decrease of 10 percentage points. In contrast, indirect maternal deaths increased from 37.2% to 45.6% (p<0.001), representing an increase of 8.4 percentage points. An increase in deaths classified as unspecified was also observed, from 2.8% to 4.4% (p=0.0068). These results indicate a transition in the profile of causes of maternal death, characterized by the increasing participation of pre-existing clinical conditions or those aggravated by pregnancy. This pattern may reflect both the increased clinical complexity of pregnant women and the impacts of the COVID-19 pandemic on maternal morbidity and mortality, especially in relation to chronic diseases and infectious conditions associated with the gestational period (Table 5).
The distribution of maternal deaths throughout the pregnancy-puerperium cycle showed relative stability in the concentration of deaths during the early puerperium (up to 42 days after delivery), which remained responsible for more than half of the deaths in both periods (58.3% versus 56.6%), without a statistically significant difference (p=0.303). Similarly, deaths occurring during pregnancy, childbirth, or abortion showed a slight proportional increase, rising from 26.5% to 29.4%, but without statistical significance (p=0.051). On the other hand, there was a significant and statistically significant reduction in late maternal deaths, occurring between 43 days and less than one year after the end of pregnancy, which decreased from 7.9% to 4.5% (p<0.001), corresponding to a relative reduction of 69.2%. This result may indicate advances in the early identification of postpartum complications or improvements in case surveillance. However, the continued high proportion of deaths during pregnancy, childbirth, and the immediate postpartum period highlights the persistence of healthcare challenges related to the management of obstetric complications and the timely follow-up of pregnant women (Table 6).
The evaluation of information quality and epidemiological surveillance indicators revealed contrasting results between the analyzed periods. A significant increase was observed in the proportion of maternal deaths that received medical assistance before death, rising from 70.9% to 79.3% (p<0.001), suggesting increased access to health services and a potential increase in opportunities for clinical intervention. However, substantial reductions were observed in two important indicators of maternal death surveillance quality. The performance of autopsies fell from 36.7% to 18.3% (p<0.001), representing a relative reduction of 73.3%. Similarly, the proportion of deaths investigated by Maternal Mortality Committees decreased from 42.9% to 32.2% (p<0.001), with a relative reduction of 59.8%. These findings are particularly concerning, since both autopsies and investigations by committees are essential strategies for correctly determining the causes of death, identifying care failures, and formulating preventive measures (Table 7).

4. Discussion

The findings of this study highlight that, despite institutional efforts represented by the guiding principles of the ReMaP Project and the objectives underpinning the Alyne Network, the healthcare system in the state of São Paulo continues to face substantial challenges in ensuring equitable maternal healthcare across its territory. The observed changes in relative risk, alongside the strengthening of the statistically significant association between race/skin color and the timing of maternal death, point to persistent racial inequities and suggest limitations in the healthcare system's capacity to adequately protect women from ethnic and racial minority groups.
This scenario indicates that strategies based solely on the physical reorganization of obstetric beds or the formal registration of pregnant women are insufficient to dismantle the barriers imposed by institutional racism and the unequal distribution of social determinants of health (SDH). Contemporary literature reinforces that integrated maternal and child health policies often fail to reach the most vulnerable populations when they do not explicitly incorporate frameworks for substantive equity and racial literacy training for screening and triage teams. Rather than mitigating asymmetries, the systemic stress experienced by care networks in recent years has acted as a catalyst for pre-existing inequities, pushing Black and Brown women toward the most severe levels of inadequate care and delays in the management of acute complications [2,3,4,12]
This exacerbation of racial disparities becomes even more critical when viewed alongside the severe dysfunction documented within the state of São Paulo’s audit and epidemiological surveillance mechanisms. A statistically alarming decline in autopsy rates, combined with the weakening of oversight and quality-improvement activities carried out by the Maternal Mortality Committees (CMM), points to a state of "institutional blindness" in the wake of the health crisis. The lack of a thorough expert review and the partial gaps in audits conducted by multidisciplinary committees create a vicious cycle that is detrimental to patient safety. Without a rigorous diagnostic clarification of a death, the accuracy in determining the underlying cause is lost; this directly compromises the assessment of whether such events could truly have been prevented and prevents the feedback loop necessary to address systemic failures within maternity units [11,13].
The direct consequences of this compromised surveillance have a synergistic impact on the shift in the documented causal profile between the periods analyzed. The observed proportional inversion characterized by a decrease in direct causes alongside an increase in indirect causes and unspecified deaths demands a cautious and in-depth scientific interpretation. While the rise in indirect causes is partly explained by the growing clinical complexity of contemporary pregnant women, who frequently present with metabolic or cardiovascular comorbidities and infections, international literature warns that a concurrent increase in ill-defined or unspecified terms is directly correlated with a scarcity of autopsies and investigations. In the absence of rigorous post-mortem audits, deaths triggered by serious failures in care during acute, direct obstetric emergencies (such as hemorrhages or pre-eclampsia) are often mislabeled under generic categories of secondary organ dysfunction [2,11].
Conversely, within an otherwise predominantly adverse epidemiological landscape, the significant reduction observed specifically in late maternal deaths emerges as the study’s most promising and successful indicator. This robust longitudinal decline suggests that care pathways focused on outpatient follow-up and extended postpartum care within both Primary Health Care (PHC) and specialized services have achieved substantial operational success. The widespread implementation of longitudinal monitoring tools—as advocated by the Alyne Network and the ReMaP dashboard has enabled the early identification and timely clinical management of chronic or residual complications that manifest beyond the traditional postpartum period, effectively safeguarding the health of these women within their home environments [6,9].
However, this progress in long-term follow-up stands in stark contrast to the indicators of hyperacute mortality observed during the immediate pregnancy-postpartum cycle. The rising proportion of deaths occurring directly during pregnancy, childbirth, or abortion compounded by persistently high mortality rates during the early postpartum period reveals a troubling paradox in healthcare delivery: this resurgence of deaths during the peripartum period is occurring alongside a significant increase in documented medical care prior to death. These findings suggest that the primary bottleneck for a sustained reduction in maternal mortality in the state of São Paulo is no longer a lack of physical access or a shortage of hospital-based medical professionals; rather, it lies in poor technical efficacy and inefficient emergency interventions at the bedside. While women are successfully reaching hospital settings and receiving care, medical teams often fail to manage acute obstetric emergencies with the necessary agility highlighting critical shortcomings in the application of clinical bundles for shock management and in the timely transfer of patients to intensive care units [9,11].
The comparison between the pre-pandemic period (2010–2019) and the pandemic/post-pandemic period (2020–2025) revealed substantial changes in the epidemiological profile of maternal mortality in the state of São Paulo. Although the total number of recorded deaths was lower in the second period (2,795 versus 1,499), these figures should be interpreted cautiously because the periods differ in duration. More importantly, the proportional distribution of deaths indicates changes in the sociodemographic, clinical, and healthcare-related characteristics of maternal mortality. Overall, the findings reveal a contrasting scenario: while some indicators showed improvement, particularly the reduction in late maternal deaths and the increased proportion of women receiving medical assistance before death, other indicators deteriorated, including racial inequalities, the proportion of indirect maternal deaths, and the performance of maternal death surveillance activities. Similar heterogeneity in maternal mortality patterns during the COVID-19 pandemic has been documented in Brazilian studies, which have highlighted the combined effects of the health crisis, pre-existing vulnerabilities, and disruptions in healthcare services [18,19,20].
Regarding racial inequalities, the proportion of maternal deaths among White women decreased from 55.7% in 2010–2019 to 50.8% in 2020–2025. Conversely, the proportion increased from 33.0% to 36.2% among Brown women and from 8.6% to 11.3% among Black women. The relative increase was particularly pronounced among Black women (+31.3%). Furthermore, the risk ratios in relation to White women increased from 0.59 to 0.71 among Brown women and from 0.15 to 0.22 among Black women. The statistically significant association between race/skin color and the period of death occurrence (χ² = 14.482; p = 0.0007) reinforces that the racial distribution of maternal deaths changed between the two periods. These findings are consistent with Silva et al. [18], who demonstrated that maternal mortality rates among Black women in Brazil were almost twice those observed among White women between 2017 and 2022, with particularly pronounced disparities in the Southeast region. The authors also identified an increase in maternal mortality among all racial groups during the COVID-19 pandemic, while the racial inequalities remained evident. This evidence reinforces the understanding that racial disparities in maternal mortality are not explained exclusively by individual socioeconomic characteristics, but are also related to structural inequalities and unequal access to timely and adequate obstetric care. Therefore, the increased proportional representation of Black and Brown women among maternal deaths in São Paulo highlights the importance of incorporating an explicit racial equity perspective into maternal healthcare policies and institutional strategies [18].
The COVID-19 pandemic further exposed the vulnerability of maternal healthcare systems to large-scale public health emergencies. Orellana et al. [19], in an analysis of excess maternal deaths in Brazil, estimated a 69% increase in maternal mortality during the first two years of the pandemic, with substantial regional differences. Similarly, Carvalho et al. [20] identified significant changes in the magnitude and spatial distribution of maternal mortality in Brazil between 2018 and 2021, demonstrating the unequal territorial impact of the pandemic. These findings provide an important epidemiological context for interpreting the differences observed between the two periods in the present study. Although the present analysis does not isolate the effects of COVID-19 from other temporal changes, the increase in the proportional participation of Black and Brown women among maternal deaths suggests that the pandemic period may have intensified vulnerabilities that were already present in the healthcare system.
Changes were also observed in the clinical profile of maternal deaths. Between the two periods, the proportion of direct maternal deaths decreased from 60.0% to 50.0%, whereas indirect maternal deaths increased from 37.2% to 45.6%; both differences were statistically significant (p < 0.001). Unspecified maternal deaths also increased, from 2.8% to 4.4% (p = 0.0068). This shift suggests a greater proportional contribution of pre-existing conditions or diseases aggravated by pregnancy during the pandemic/post-pandemic period. Evidence from the state of Rio de Janeiro supports this interpretation. Bellizzi et al. [21], analyzing maternal and late maternal mortality between 2009 and 2021, found that indirect causes became predominant during the COVID-19 pandemic, particularly due to viral infections, including COVID-19. The authors also observed an increase in mortality associated with hypertensive disorders during pandemic periods. These findings reinforce the possibility that the pandemic affected maternal mortality not only through direct infection but also through the exacerbation of pre-existing clinical conditions and the challenges of maintaining adequate care during pregnancy and the postpartum period [19,20,21]. Nevertheless, the simultaneous increase in unspecified deaths and the reduction in post-mortem investigations in the present study indicate that changes in diagnostic classification and surveillance quality may also have influenced the observed distribution. Therefore, these findings should not be interpreted exclusively as evidence of a change in the underlying causes of maternal mortality.
Regarding the timing of maternal deaths, the comparison demonstrated that deaths occurring during pregnancy, childbirth, or abortion increased from 26.5% to 29.4%, although this difference did not reach statistical significance (p = 0.051). Deaths occurring during the first 42 days postpartum remained the predominant category in both periods, accounting for 58.3% and 56.6%, respectively, with no statistically significant difference (p = 0.303). In contrast, late maternal deaths, occurring between 43 days and less than one year after the end of pregnancy, decreased significantly from 7.9% to 4.5% (p < 0.001). This reduction may indicate changes in the identification, classification, or management of complications during extended postpartum follow-up. However, the interpretation of this finding requires caution, particularly because late maternal deaths are frequently underreported and may be affected by limitations in death certification and surveillance systems. Bellizzi et al. [21] emphasize the importance of identifying and classifying late maternal deaths more accurately, demonstrating that the inclusion of deaths occurring beyond the conventional 42-day postpartum period provides a broader understanding of maternal mortality. Their findings also highlight the need to extend postpartum follow-up, particularly for women with cardiovascular, hypertensive, and other chronic conditions that may emerge or worsen after childbirth. Accordingly, despite the reduction observed in São Paulo, the proportion of late maternal deaths should remain an important indicator for monitoring the continuity and quality of postpartum care [21].
The comparison of healthcare and surveillance indicators revealed another important contrast between the periods. The proportion of women who received medical assistance before death increased from 70.9% in 2010–2019 to 79.3% in 2020–2025 (p < 0.001). Although this finding may suggest greater contact with healthcare services, the increase in medical assistance did not correspond to improvements in all dimensions of maternal care. The proportion of deaths investigated by Maternal Mortality Committees decreased from 42.9% to 32.2%, while the proportion of deaths with no information regarding investigation increased from 22.9% to 34.6%. Similarly, the proportion of deaths in which an autopsy was performed declined from 36.7% to 18.3% (p < 0.001). These reductions are particularly concerning because maternal death investigations and post-mortem examinations are essential for clarifying causes of death, identifying preventable circumstances, and informing improvements in healthcare delivery. De Mucio et al. [22] emphasize that systematic investigation, the identification of suspected maternal deaths, the reclassification of incorrectly recorded cases, and the integration of different information sources are fundamental strategies for improving the quality of maternal mortality data. In addition, the Society for Maternal-Fetal Medicine [23] highlights the role of maternal mortality review committees in identifying preventable factors and developing recommendations to improve the quality and safety of maternal healthcare. Thus, the findings of the present study suggest that increased contact with healthcare services coexisted with substantial weaknesses in the institutional mechanisms responsible for evaluating and preventing maternal deaths.
Taken together, the comparison between 2010–2019 and 2020–2025 demonstrates that maternal mortality in São Paulo underwent important changes, but these changes were not uniformly favorable. The reduction in late maternal deaths and the increased proportion of deaths preceded by medical assistance represent potentially positive developments. Conversely, the increased participation of Black and Brown women among maternal deaths, the higher proportion of indirect and unspecified deaths, and the decline in autopsies and investigations by Maternal Mortality Committees indicate persistent challenges in achieving equitable and effective maternal healthcare. These findings are consistent with recent Brazilian evidence demonstrating that racial inequalities, the burden of indirect causes, and weaknesses in maternal death surveillance remain important barriers to reducing preventable maternal mortality [18,19,20,21,22].
The primary limitation of this study lies in its ecological nature and its direct reliance on secondary data from the Mortality Information System (SIM), accessed via the ReMaP dashboard. This approach exposes the analysis to instabilities stemming from historical underreporting and variations in the quality of how death certificates are completed across municipalities in the state of São Paulo. A clear example of this vulnerability is the lack of reliable data for the "educational attainment" variable between 2010 and 2014, which precluded a complete, linear assessment of this socioeconomic indicator throughout the entire study period. Furthermore, because the study is based on aggregated data, the epidemiological findings reflect population-level and territorial trends, precluding causal inferences or risk associations at the strictly individual level.
Conversely, the study makes a robust scientific and methodological contribution by providing a precise, up-to-date epidemiological assessment of the state of São Paulo. By segmenting and comparing the periods before and after the systemic stress caused by the COVID-19 pandemic, the research reveals with mathematical precision—the worsening of racial disparities and a concerning decline in expert audit mechanisms (such as autopsies and investigations by review committees). These findings extend beyond the academic sphere, serving as an immediate strategic resource for public policymakers; they provide guidance for the redesign and funding of integrated networks such as ReMaP and the Alyne Network with a focus on improving acute hospital outcomes and fostering racial equity.

5. Conclusions

The findings of this study reveal important changes in the epidemiological profile of maternal mortality in the state of São Paulo between 2010–2019 and 2020–2025, providing evidence to assess the maternal healthcare context surrounding the emergence of the ReMaP Project and the establishment of the Alyne Network. Although the temporal comparison identified improvements in some indicators, particularly the reduction in late maternal deaths (from 7.9% to 4.5%) and the increased proportion of women receiving medical assistance before death (from 70.9% to 79.3%), these changes occurred alongside persistent and worsening challenges in maternal healthcare.
The most concerning findings include the increased proportional representation of Black and Brown women among maternal deaths, with a particularly pronounced increase among Black women (from 8.6% to 11.3%), as well as the rise in indirect maternal deaths (from 37.2% to 45.6%). Furthermore, the proportion of deaths occurring during pregnancy, childbirth, or abortion increased from 26.5% to 29.4%, although this difference did not reach statistical significance, while deaths during the first 42 days postpartum remained predominant. These findings highlight the persistence of inequalities and the need to strengthen comprehensive maternal healthcare, particularly through timely identification and management of obstetric complications and conditions aggravated by pregnancy.
An additional concern is the deterioration of maternal death surveillance indicators, evidenced by the reduction in autopsy performance (from 36.7% to 18.3%) and investigations conducted by Maternal Mortality Committees (from 42.9% to 32.2%). These weaknesses may compromise the accurate identification of underlying causes, the assessment of preventability, and the development of effective strategies to improve the quality of maternal healthcare. In response to the research question, the temporal changes observed suggest that the emergence of the ReMaP Project and the establishment of the Alyne Network occurred within a period marked by important transformations in maternal mortality patterns. However, the findings do not allow these changes to be directly attributed to the implementation of these initiatives. Rather, they demonstrate that institutional restructuring and the expansion of coordinated maternal healthcare policies must be accompanied by measurable improvements in clinical care, epidemiological surveillance, and racial equity.
Therefore, strengthening maternal healthcare in São Paulo requires sustained investment in the quality and continuity of obstetric care, the timely management of direct and indirect maternal complications, the recovery of the investigative capacity of Maternal Mortality Committees, and the implementation of explicit strategies to confront institutional racism. Incorporating an intersectional and reproductive justice perspective into the ReMaP Project and the Alyne Network is essential to ensure that improvements in maternal health are translated into equitable outcomes for all women, particularly Black and Brown women. Continuous monitoring of maternal mortality indicators, disaggregated by sociodemographic and clinical characteristics, will be fundamental to evaluating future progress and guiding public policies toward the prevention of avoidable maternal deaths and the achievement of national and global maternal health targets.

Author Contributions

Conceptualization, G.G.d.S.; methodology, G.G.d.S; software, G.G.d.S; validation, G.G.d.S.; formal analysis, G.G.d.S, G.d.S.C, K.C.P.M.V, C.M.P.d.S and C.d.O; investigation, G.G.d.S, G.d.S.C, K.C.P.M.V, P.W.P, C.M.P.d.S, B.C.R.C.M, R.J.O.M, A.d.S.O, A.S.G.T, M.C.d.G.M, C.d.O, R.P.P and E.M; writing—original draft preparation, G.G.d.S, G.d.S.C, K.C.P.M.V, P.W.P, C.M.P.d.S, B.C.R.C.M, R.J.O.M, A.d.S.O, A.S.G.T, M.C.d.G.M, C.d.O, R.P.P and E.M.; writing—review and editing, G.G.d.S, G.d.S.C, K.C.P.M.V, P.W.P, C.M.P.d.S, B.C.R.C.M, R.J.O.M, A.d.S.O, A.S.G.T, M.C.d.G.M, C.d.O, R.P.P and E.M.; visualization, G.G.d.S.; supervision, G.G.d.S; project administration, G.G.d.S. All authors have read and agreed to the published version of the manuscript

Funding

This research received no external funding

Institutional Review Board Statement

This study did not directly involve human beings or animals and, therefore, did not require approval from a research ethics committee

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article

Acknowledgments

Research Group on Nursing Care in Women’s Health/Observatory of Technological Innovations in Women’s Health—Intersectionality, Race and Gender (GPCESM/OTIRG-Mulheres), Guarulhos University (UnG).

Conflicts of Interest

The authors declare no conflicts of interest

Abbreviations

CMM Maternal Mortality Committee
COVID-19 Coronavirus Disease 2019
ICD-10 International Statistical Classification of Diseases and Related Health Problems, Tenth Revision
MMC Maternal Mortality Committee
MMR Maternal Mortality Ratio
OOBr Brazilian Obstetric Observatory (Observatório Obstétrico Brasileiro)
PHC Primary Health Care
ReMaP Restructuring and Redesign of the Maternal and Perinatal Care Network (Reestruturação e Redesenho da Rede de Atenção Materna e Perinatal)
RR Risk Ratio
SDH Social Determinants of Health
SDOH Social Determinants of Health
SDGs Sustainable Development Goals
SIM Mortality Information System (Sistema de Informações sobre Mortalidade)
STROBE Strengthening the Reporting of Observational Studies in Epidemiology
WHO World Health Organization

References

  1. World Health Organization (WHO). Maternal mortality. 7 Mar 2025. Available online: https://www.who.int/news-room/fact-sheets/detail/maternal-mortality.
  2. Lee, S.; Kim, S.; Lee, H.; Park, J.; Son, Y.; López Sánchez, G.F.; Pizzol, D.; Lee, J.; Lee, Y.J.; Lee, H.; Kim, H.J.; Smith, L.; Woo, S.; Yon, D.K. Global, Regional, and National Trends in Maternal Mortality Ratio Across 37 High Income Countries From 1990 to 2021, With Projections up to 2050: A Comprehensive Analysis From the WHO Mortality Database. J. Korean Med. Sci. 2025, 40(21), e85. [Google Scholar] [CrossRef]
  3. Safarzadeh, A. Dismantling inequities to end the black maternal mortality crisis in the United States. Int. J. Equity Health 2025, 24(1), 114. [Google Scholar] [CrossRef]
  4. Kamijo, K.; Hayasaka, M.; Kawakita, T. Racial Disparities in Maternal Mortality Before, During, and After the COVID-19 Pandemic in the United States: A Difference-in-Difference Analysis. Cureus 2025, 17(8), e90416. [Google Scholar] [CrossRef]
  5. Vousden, N.; Bunch, K.; Kenyon, S.; Kurinczuk, J.J.; Knight, M. Impact of maternal risk factors on ethnic disparities in maternal mortality: a national population-based cohort study. Lancet Reg. Health Eur. 2024, 40, 100893. [Google Scholar] [CrossRef]
  6. Neerland, C.; Slaughter-Acey, J.; Behrens, K.; Claussen, A.M.; Usset, T.; Bilal-Roby, S.; Bashir, H.; Westby, A.; Wagner, B.; McAlpine, D.; Dixon, M.; Xiao, M.; Avila, D.; Butler, M. An Evidence Map for Social and Structural Determinants for Maternal Morbidity and Mortality: A Systematic Review. Obstet. Gynecol. 2024, 143(3), 383–392. [Google Scholar] [CrossRef]
  7. Slaughter-Acey, J.; Behrens, K.; Claussen, A.M.; Usset, T.; Neerland, C.; Bilal-Roby, S.; Bashir, H.; Westby, A.; Wagner, B.; Dixon, M.; Xiao, M.; Butler, M. Social and Structural Determinants of Maternal Morbidity and Mortality: An Evidence Map [Internet]; Agency for Healthcare Research and Quality (US): Rockville (MD), Dec 2023; pp. 23(24)–EHC014. [Google Scholar] [CrossRef]
  8. Geddes-Barton, D.; Baldelli, S.; Karthikappallil, R.; Bentley, T.; Omorodion, B.; Thompson, L.; Roberts, N.W.; Goldacre, R.; Knight, M.; Ramakrishnan, R. Association between socioeconomic disadvantage and severe maternal morbidity and mortality in high-income countries: a systematic review. J. Epidemiol. Community Health 2025, 79(3), 207–215. [Google Scholar] [CrossRef]
  9. Abie, A.; Getie Mehari, M.; Eseyneh Dagnew, T.; Mebrat Delie, A.; Melese, M.; Workie Limenh, L.; Kassie Worku, N.; Talie Fenta, E.; Esubalew, D.; Hailu, M. Obstetric admission and maternal mortality in the intensive care unit in Africa: A systematic review and meta-analysis. PLoS ONE 2025, 20(4), e0320254. [Google Scholar] [CrossRef]
  10. Japan Maternal Death Exploratory Committee. Proposals for improving maternal safety (2023 edition): Insights from the analysis of maternal deaths in Japan. J. Obstet. Gynaecol. Res. 2025, 51(3), e16244. [Google Scholar] [CrossRef]
  11. Dilmaghani, D.; Nath, K.A.; Garovic, V.D. Increasing Maternal Mortality in the United States: Looking Beneath and Beyond the Numbers. Mayo Clin. Proc. 2024, 99(6), 873–877. [Google Scholar] [CrossRef]
  12. Rowley, D.L.; Anyanwu, K.; Crosby, A.; Phillips, K.S.; Hutchins, S. Pregnancy-Related Mortality Disparities During the COVID-19 Pandemic. Am. J. Public Health 2024, 114(S9), S723–S730. [Google Scholar] [CrossRef]
  13. Rossen, L.M.; Hoyert, D.L.; Horon, I.; Branum, A.M. Trends in maternal mortality rates by state, United States, 2018 to 2023. Am. J. Obstet. Gynecol. 2026, 234(1), 250–269. [Google Scholar] [CrossRef]
  14. Wang, E.; Glazer, K.B.; Howell, E.A.; Janevic, T.M. Social Determinants of Pregnancy-Related Mortality and Morbidity in the United States: A Systematic Review. Obstet. Gynecol. 2020, 135(4), 896–915. [Google Scholar] [CrossRef]
  15. von Elm, E.; Altman, D.G.; Egger, M.; Pocock, S.J.; Gøtzsche, P.C.; Vandenbroucke, J.P.; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007, 335(7624), 806–8. [Google Scholar] [CrossRef]
  16. Rodrigues, A.; Lacerda, L.; Francisco, R.P.V. Brazilian Obstetric Observatory. arXiv arXiv:2105.06534. [CrossRef]
  17. Brasil. Ministério da Saúde. Conselho Nacional de Saúde. Resolução nº 466, de 12 de dezembro de 2012. Aprova diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Diário Of. Da União 2013, Seção 1, 59. [Google Scholar]
  18. Silva, A.D.; Guida, J.P.S.; Santos, D.S.; Santiago, S.M.; Surita, F.G. Racial disparities and maternal mortality in Brazil: findings from a national database. Rev. Saude Publica 2024, 58, 25. [Google Scholar] [CrossRef]
  19. Orellana, J.D.Y.; Leventhal, D.G.P.; Flores-Quispe, M.D.; Marrero, L.; Jacques, N.; Morón-Duarte, L.S.; et al. Impact of the COVID-19 pandemic on excess maternal deaths in Brazil: a two-year assessment. PLoS ONE 2024, 19(4), e0298822. [Google Scholar] [CrossRef]
  20. Carvalho, I.C.S.; Mascarenhas, M.D.M.; Rodrigues, M.T.P.; Andrade, J.X.; Nascimento, F.F.; Penha, J.C. Impact of the Covid-19 pandemic on the maternal mortality rate in Brazil: trend and spatial distribution. Rev. Gauch. Enferm. 2024, 45, e20230299. [Google Scholar] [CrossRef]
  21. Bellizzi, A.L.M.; Kale, P.L.; Fonseca, S.C.; Cascão, A.M. Causes of maternal death and late maternal mortality: from the H1N1 to COVID-19 pandemics, State of Rio de Janeiro, 2009 to 2021. Rev. Bras. Saude Mater. Infant. 2025, 25, e20250118. [Google Scholar] [CrossRef]
  22. De Mucio, B.; Sanhueza, A.; Soliz, P.; García Saiso, S.; Serruya, S.; Jiménez, A.P.; et al. Intentional search and reclassification of maternal deaths: quality information and its analysis to reduce maternal mortality. Rev. Panam. Salud Publica 2024, 48, e116. [Google Scholar] [CrossRef]
  23. Society for Maternal-Fetal Medicine; Teal, E.N.; Jones, C.W.; Balogun, O.A.; Robbins, L.S.; SMFM Health Policy and Advocacy Committee. Society for Maternal-Fetal Medicine position statement: maternal mortality review committees. Pregnancy 2025, 1(3), e70019. [Google Scholar] [CrossRef]
Table 1. Distribution of sociodemographic characteristics of maternal deaths according to period of occurrence, Brazil, 2010–2019 and 2020–2025.
Table 1. Distribution of sociodemographic characteristics of maternal deaths according to period of occurrence, Brazil, 2010–2019 and 2020–2025.
Variable 2010–2019 n (%) 2020–2025 n (%)
Race/color
Yellow 9 (0.3%) 3 (0.2%)
White 1,557 (55.7%) 762 (50.8%)
Ignored 67 (2.4%) 21 (1.4%)
Indigenous 1 (<0.1%) 2 (0.1%)
Brown 921 (33.0%) 542 (36.2%)
Black 240 (8.6%) 169 (11.3%)
Education*
Elementary School I 109 (3.9%) 72 (4.8%)
Middle School (Grades 6-8) 381 (13.6%) 257 (17.1%)
Ignored 1,236 (44.2%) 162 (10.8%)
Average 617 (22.1%) 758 (50.6%)
No schooling 7 (0.3%) 7 (0.5%)
Bachelor's degree 159 (5.7%) 198 (13.2%)
Incomplete higher education 55 (2.0%) 45 (3.0%)
Marital status
Married 942 (33.7%) 549 (36.6%)
Not married 1,399 (50.1%) 673 (44.9%)
Common-law marriage 250 (8.9%) 170 (11.3%)
Legally separated/Divorced 87 (3.1%) 48 (3.2%)
Widow/Widower 21 (0.8%) 6 (0.4%)
Ignored 96 (3.4%) 53 (3.5%)
Total 2.795 (100.0%) 1.499 (100.0%)
*For the education variable, the records from 2010–2014 were entirely classified as "unknown" in the available database. Furthermore, the percentages were recalculated using the total number of maternal deaths for each period as the denominator, allowing for a direct comparison between the pre-pandemic (2010–2019) and pandemic/post-pandemic (2020–2025) periods.
Table 2. Distribution of obstetric characteristics and underlying cause of maternal deaths according to period of occurrence, Brazil, 2010–2019 and 2020–2025.
Table 2. Distribution of obstetric characteristics and underlying cause of maternal deaths according to period of occurrence, Brazil, 2010–2019 and 2020–2025.
Variable 2010–2019 n (%) 2020–2025 n (%)
Period of death
During pregnancy, childbirth, or abortion. 741 (26.5%) 440 (29.4%)
During the postpartum period, up to 42 days. 1,630 (58.3%) 849 (56.6%)
During the postpartum period, from 43 days to <1 year. 221 (7.9%) 68 (4.5%)
Not informed or ignored 134 (4.8%) 113 (7.5%)
Not during pregnancy or the postpartum period. 41 (1.5%) 29 (1.9%)
Inconsistent period** 28 (1.0%) 0 (0.0%)
Type of maternal death
Direct 1,677 (60.0%) 750 (50.0%)
Indirect 1,040 (37.2%) 683 (45.6%)
Not specified 78 (2.8%) 66 (4.4%)
ICD-10 Chapter***
I – Some infectious and parasitic diseases 50 (1.8%) 0 (0.0%)
II – Neoplasms (tumors) 1 (<0.1%) 0 (0.0%)
V – Mental and behavioral disorders 1 (<0.1%) 1 (<0.1%)
XV – Pregnancy, childbirth and the postpartum period 2,743 (98.1%) 1,498 (99.9%)
Other chapters 0 (0.0%) 0 (0.0%)
Total* 2.795 (100.0%) 1.499 (100.0%)
*Percentages were recalculated considering the total number of maternal deaths in each period (2010–2019: n=2,795; 2020–2025: n=1,499). **For the period 2020–2025, no records classified as "Inconsistent Period" were observed. ***In the ICD-10 chapter, practically all maternal deaths remained classified in Chapter XV (Pregnancy, childbirth and the puerperium) in both periods. A proportional reduction in direct maternal deaths (60.0% to 50.0%) and an increase in indirect deaths (37.2% to 45.6%) were observed between the periods analyzed.
Table 3. Distribution of care and investigation characteristics of maternal deaths according to period of occurrence, Brazil, 2010–2019 and 2020–2025.
Table 3. Distribution of care and investigation characteristics of maternal deaths according to period of occurrence, Brazil, 2010–2019 and 2020–2025.
Variable 2010–2019 n (%) 2020–2025 n (%)
Location of occurrence
Home 84 (3.0%) 51 (3.4%)
Hospital* 2,590 (92.7%) 1,378 (91.9%)
Another health facility 85 (3.0%) 55 (3.7%)
Other locations 31 (1.1%) 13 (0.9%)
Public road 5 (0.2%) 2 (0.1%)
Medical assistance**
With assistance 1,982 (70.9%) 1,189 (79.3%)
Without assistance 97 (3.5%) 45 (3.0%)
Ignored 716 (25.6%) 265 (17.7%)
Necropsy
Yes 1,027 (36.7%) 274 (18.3%)
No 1,466 (52.5%) 964 (64.3%)
Ignored 302 (10.8%) 261 (17.4%)
Investigation by the Maternal Mortality Committee (MMC)***
Yes 1,198 (42.9%) 482 (32.2%)
No 958 (34.3%) 499 (33.3%)
No information 639 (22.9%) 518 (34.6%)
Total 2.795 (100.0%) 1.499 (100.0%)
The percentages were recalculated using the total number of maternal deaths for each period as the denominator (2010–2019: n=2,795; 2020–2025: n=1,499). *Hospital occurrences predominated in both periods (>90%). **There was a proportional increase in records with medical assistance (70.9% to 79.3%) and a reduction in autopsies performed (36.7% to 18.3%) between the periods. ***A decrease was also observed in the proportion of cases investigated by Maternal Mortality Committees (42.9% to 32.2%) and an increase in records without information on investigation (22.9% to 34.6%).
Table 4. Disparities social factors and Risk Ratios for Maternal Mortality in São Paulo, 2010-2019 and 2020-2025.
Table 4. Disparities social factors and Risk Ratios for Maternal Mortality in São Paulo, 2010-2019 and 2020-2025.
Race/Color 2010-2019 % 2010-2019 2020-2025 % 2020-2025 Relative Variation RR* 2010-2019 RR*2020-2025
White 1,557 55.7% 762 50.8% -8.7% 1.00 1.00
Brown 921 33.0% 542 36.2% +9.7% 0.59 0.71
Black 240 8.6% 169 11.3% +31.3% 0.15 0.22
χ² test χ² = 14.482 p = 0.0007 *** - - - -
*RR = Risk Ratio in relation to white women. χ² = chi-square test for association between race/color and period. *** p<0.001 (highly significant). Interpretation: There is a statistically significant association between race/color and period of occurrence. Black and brown women represented an increasing proportion of maternal deaths in the recent period, suggesting persistence or worsening of racial inequalities in maternal mortality.
Table 5. Type of death maternal by period according to analysis of changes temporal.
Table 5. Type of death maternal by period according to analysis of changes temporal.
Type of death 2010-2019 2010-2019 2020-2025 2020-2025 Var. Abs.(pp) Relative Variance (%) p-value
Direct 1,677 60.0% 750 50.0% -10.0 -55.3 <0.001***
Indirect 1.040 37.2% 683 45.6% +8.4 -34.3 <0.001***
Not specified 78 2.8% 66 4.4% +1.6 -15.4 0.0068**
Total 2,795 100.0% 1,499 100.0% - - -
pp = percentage points. Abs. Var. = Absolute Variation. Rel. Var. = Relative Variation. *** p <0.001; ** p<0.01. Interpretation: Significant reduction in direct deaths (60.0% → 50.0%, p<0.001) and significant increase in indirect deaths (37.2% → 45.6%, p<0.001), suggesting a greater contribution from pre-existing clinical conditions amplified by pregnancy in the recent period.
Table 6. Period of the bio maternal by period according to analysis is temporal.
Table 6. Period of the bio maternal by period according to analysis is temporal.
Period of Death 2010-2019 2010-2019 2020-2025 2020-2025 Var. Abs.(pp) Relative Variance (%) p-value
Pregnancy/Childbirth/Abortion 741 26.5% 440 29.4% +2.8 -40.6 0.051ns
Postpartum period ≤42 days 1,630 58.3% 849 56.6% -1.7 -47.9 0.303ns
Postpartum period 43 days - 1 year 221 7.9% 68 4.5% -3.4 -69.2 <0.001***
Total (excluding others) 2,592 100.0% 1.357 100.0% - - -
ns=not significant; *** p<0.001. Interpretation: Significant reduction in late deaths (7.9% → 4.5%, p<0.001, relative reduction of 69.2%), suggesting a possible improvement in postpartum surveillance. However, perinatal deaths (pregnancy/delivery/abortion) show a trend towards increase (26.5% → 29.4%), indicating the persistence of complications of the pregnancy-puerperal cycle.
Table 7. Indicators of quality of dados and vigilance and epidemiological.
Table 7. Indicators of quality of dados and vigilance and epidemiological.
Indicator n/% 2010-2019 n/% 2020-2025 Var. Abs. (pp) Relative Variance (%) p-value Direction
With medical assistance 1,982 (70.9%) 1,189 (79.3%) +8.4 -40.0 <0.001*** ↑ Improvement
Performing an autopsy 1,027 (36.7%) 274 (18.3%) -18.4 -73.3 <0.001*** Review
Investigation by CMM 1,198 (42.9%) 482 (32.2%) -10.7 -59.8 <0.001*** Review
CMM = Maternal Mortality Committee. pp = percentage points. *** p<0.001 (highly significant). Drastic and significant reduction in autopsies (36.7% → 18.3%, 73.3% reduction, p <0.001) and investigations by CMM (42.9% → 32.2%, 59.8% reduction, p<0.001). This affects the diagnostic accuracy of causes of death and compromises epidemiological surveillance. On the other hand, medical care increased significantly (70.9% → 79.3%), suggesting that more women receive care before death, potentially improving opportunities for intervention.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.